Novel motif:63: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:51, 9 September 2013
name: | motif63_GTNCCA |
---|
![](/5/sstar/seqlogos/novel/63.png)
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0046655 | folic acid metabolic process | 4.647283e-10 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.491502e-9 |
GO:0015705 | iodide transport | 6.120519e-9 |
GO:0045820 | negative regulation of glycolysis | 1.537799e-8 |
GO:0043249 | erythrocyte maturation | 1.661584e-8 |
GO:0003009 | skeletal muscle contraction | 1.910765e-8 |
GO:0051241 | negative regulation of multicellular organismal process | 2.017385e-8 |
GO:0051412 | response to corticosterone stimulus | 2.309338e-8 |
GO:0007585 | respiratory gaseous exchange | 2.522161e-8 |
GO:0006544 | glycine metabolic process | 3.115249e-8 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.914456e-8 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.192059e-8 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 4.682865e-8 |
GO:0006449 | regulation of translational termination | 5.644451e-8 |
GO:0003016 | respiratory system process | 5.775123e-8 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 6.485054e-8 |
GO:0060535 | trachea cartilage morphogenesis | 7.287085e-8 |
GO:0060669 | embryonic placenta morphogenesis | 7.524484e-8 |
GO:0006575 | cellular modified amino acid metabolic process | 7.781067e-8 |
GO:0060749 | mammary gland alveolus development | 8.130647e-8 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 8.552175e-8 |
GO:0032312 | regulation of ARF GTPase activity | 1.126553e-7 |
GO:0007165 | signal transduction | 1.391611e-7 |
GO:0050881 | musculoskeletal movement | 1.540223e-7 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.917627e-7 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 2.125935e-7 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 2.125935e-7 |
GO:0051716 | cellular response to stimulus | 2.366565e-7 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.475580e-7 |
GO:0046939 | nucleotide phosphorylation | 2.891255e-7 |
GO:0051385 | response to mineralocorticoid stimulus | 2.899901e-7 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 3.541017e-7 |
GO:0060482 | lobar bronchus development | 5.005591e-7 |
GO:0009629 | response to gravity | 6.083802e-7 |
GO:0006304 | DNA modification | 1.084551e-6 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 1.113514e-6 |
GO:0031330 | negative regulation of cellular catabolic process | 1.139902e-6 |
GO:0009071 | serine family amino acid catabolic process | 1.207045e-6 |
GO:0006695 | cholesterol biosynthetic process | 1.334047e-6 |
GO:0007568 | aging | 1.517336e-6 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.556578e-6 |
GO:0044281 | small molecule metabolic process | 1.579422e-6 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.682002e-6 |
GO:0006754 | ATP biosynthetic process | 1.682060e-6 |
GO:0006760 | folic acid-containing compound metabolic process | 2.008680e-6 |
GO:0060534 | trachea cartilage development | 2.049976e-6 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 2.160088e-6 |
GO:0006213 | pyrimidine nucleoside metabolic process | 2.272584e-6 |
GO:0010889 | regulation of sequestering of triglyceride | 2.387859e-6 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.443691e-6 |
GO:0030277 | maintenance of gastrointestinal epithelium | 2.573680e-6 |
GO:0008215 | spermine metabolic process | 3.037449e-6 |
GO:0001974 | blood vessel remodeling | 3.047252e-6 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 3.184120e-6 |
GO:0048144 | fibroblast proliferation | 3.426544e-6 |
GO:0045056 | transcytosis | 3.470385e-6 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 3.582778e-6 |
GO:0016126 | sterol biosynthetic process | 3.624737e-6 |
GO:0034340 | response to type I interferon | 3.758095e-6 |
GO:0035556 | intracellular signal transduction | 4.538975e-6 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 4.560195e-6 |
GO:0006982 | response to lipid hydroperoxide | 4.851808e-6 |
GO:0006820 | anion transport | 5.288589e-6 |
GO:0015698 | inorganic anion transport | 5.564004e-6 |
GO:0060337 | type I interferon-mediated signaling pathway | 6.140621e-6 |
GO:0019388 | galactose catabolic process | 6.354155e-6 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 6.536762e-6 |
GO:0030195 | negative regulation of blood coagulation | 6.571694e-6 |
GO:0006546 | glycine catabolic process | 6.652125e-6 |
GO:0002238 | response to molecule of fungal origin | 6.730650e-6 |
GO:0010288 | response to lead ion | 6.775922e-6 |
GO:0044275 | cellular carbohydrate catabolic process | 7.569650e-6 |
GO:0046208 | spermine catabolic process | 7.728913e-6 |
GO:0016052 | carbohydrate catabolic process | 7.830774e-6 |
GO:0006955 | immune response | 8.188092e-6 |
GO:0060708 | spongiotrophoblast differentiation | 8.431392e-6 |
GO:0006720 | isoprenoid metabolic process | 8.724797e-6 |
GO:0046365 | monosaccharide catabolic process | 9.239685e-6 |
GO:0032526 | response to retinoic acid | 9.479356e-6 |
GO:0009069 | serine family amino acid metabolic process | 9.557874e-6 |
GO:0060707 | trophoblast giant cell differentiation | 9.804061e-6 |
GO:0006621 | protein retention in ER lumen | 1.027659e-5 |
GO:0008299 | isoprenoid biosynthetic process | 1.127677e-5 |
GO:0072061 | inner medullary collecting duct development | 1.199551e-5 |
GO:0072060 | outer medullary collecting duct development | 1.199551e-5 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.199551e-5 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 1.213678e-5 |
GO:0032203 | telomere formation via telomerase | 1.233744e-5 |
GO:0048631 | regulation of skeletal muscle tissue growth | 1.291485e-5 |
GO:0050902 | leukocyte adhesive activation | 1.308674e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.308674e-5 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.340511e-5 |
GO:0042403 | thyroid hormone metabolic process | 1.426182e-5 |
GO:0032689 | negative regulation of interferon-gamma production | 1.441501e-5 |
GO:0030641 | regulation of cellular pH | 1.525230e-5 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.558972e-5 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.584104e-5 |
GO:0051453 | regulation of intracellular pH | 1.607359e-5 |
GO:0030225 | macrophage differentiation | 1.637280e-5 |
GO:0006885 | regulation of pH | 1.651216e-5 |
GO:0051452 | intracellular pH reduction | 1.676251e-5 |
GO:0046135 | pyrimidine nucleoside catabolic process | 1.768994e-5 |
GO:0045123 | cellular extravasation | 1.821068e-5 |
GO:0048771 | tissue remodeling | 1.842875e-5 |
GO:0042908 | xenobiotic transport | 1.940119e-5 |
GO:0023052 | signaling | 1.947717e-5 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.967411e-5 |
GO:0009116 | nucleoside metabolic process | 1.993555e-5 |
GO:0043542 | endothelial cell migration | 2.006618e-5 |
GO:0019320 | hexose catabolic process | 2.042277e-5 |
GO:0032796 | uropod organization | 2.150416e-5 |
GO:0006826 | iron ion transport | 2.260611e-5 |
GO:0031960 | response to corticosteroid stimulus | 2.288156e-5 |
GO:0043320 | natural killer cell degranulation | 2.319650e-5 |
GO:0006520 | cellular amino acid metabolic process | 2.346979e-5 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 2.527881e-5 |
GO:0034097 | response to cytokine stimulus | 2.571169e-5 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 2.593252e-5 |
GO:0032202 | telomere assembly | 2.597044e-5 |
GO:0009298 | GDP-mannose biosynthetic process | 2.618671e-5 |
GO:0018094 | protein polyglycylation | 2.625439e-5 |
GO:0045604 | regulation of epidermal cell differentiation | 2.948007e-5 |
GO:0009268 | response to pH | 2.965769e-5 |
GO:0045851 | pH reduction | 3.006168e-5 |
GO:0042398 | cellular modified amino acid biosynthetic process | 3.084245e-5 |
GO:0060574 | intestinal epithelial cell maturation | 3.175529e-5 |
GO:0009308 | amine metabolic process | 3.188754e-5 |
GO:0030719 | P granule organization | 3.362108e-5 |
GO:0006810 | transport | 3.445400e-5 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.623057e-5 |
GO:0051248 | negative regulation of protein metabolic process | 3.742603e-5 |
GO:0006066 | alcohol metabolic process | 3.869969e-5 |
GO:0012502 | induction of programmed cell death | 3.935948e-5 |
GO:0006694 | steroid biosynthetic process | 4.049105e-5 |
GO:0003059 | positive regulation of the force of heart contraction by epinephrine | 4.124777e-5 |
GO:0043243 | positive regulation of protein complex disassembly | 4.183483e-5 |
GO:0002920 | regulation of humoral immune response | 4.211533e-5 |
GO:0048246 | macrophage chemotaxis | 4.286750e-5 |
GO:0051384 | response to glucocorticoid stimulus | 4.465616e-5 |
GO:0015893 | drug transport | 4.492495e-5 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 4.551903e-5 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4.625886e-5 |
GO:0071347 | cellular response to interleukin-1 | 4.765048e-5 |
GO:0051289 | protein homotetramerization | 4.765048e-5 |
GO:0030198 | extracellular matrix organization | 4.859912e-5 |
GO:0009119 | ribonucleoside metabolic process | 4.890129e-5 |
GO:0021754 | facial nucleus development | 4.927583e-5 |
GO:0010631 | epithelial cell migration | 4.958835e-5 |
GO:0051234 | establishment of localization | 5.042381e-5 |
GO:0001977 | renal system process involved in regulation of blood volume | 5.081878e-5 |
GO:0060711 | labyrinthine layer development | 5.143362e-5 |
GO:0006821 | chloride transport | 5.192132e-5 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 5.232962e-5 |
GO:0006917 | induction of apoptosis | 5.245925e-5 |
GO:0060056 | mammary gland involution | 5.579178e-5 |
GO:0007028 | cytoplasm organization | 5.626114e-5 |
GO:0035811 | negative regulation of urine volume | 5.640340e-5 |
GO:0050896 | response to stimulus | 5.656005e-5 |
GO:0009698 | phenylpropanoid metabolic process | 6.030516e-5 |
GO:0032269 | negative regulation of cellular protein metabolic process | 6.231490e-5 |
GO:0050909 | sensory perception of taste | 6.288705e-5 |
GO:0030878 | thyroid gland development | 6.294151e-5 |
GO:0042446 | hormone biosynthetic process | 6.325796e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 6.555901e-5 |
GO:0060712 | spongiotrophoblast layer development | 6.733908e-5 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 6.832823e-5 |
GO:0000093 | mitotic telophase | 6.850888e-5 |
GO:0009628 | response to abiotic stimulus | 6.889308e-5 |
GO:0018293 | protein-FAD linkage | 6.994383e-5 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 6.994383e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 6.994383e-5 |
GO:0072110 | glomerular mesangial cell proliferation | 7.196203e-5 |
GO:0007154 | cell communication | 7.245305e-5 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 7.293092e-5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.458694e-5 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 7.925076e-5 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 7.925076e-5 |
GO:0045947 | negative regulation of translational initiation | 7.952733e-5 |
GO:0006446 | regulation of translational initiation | 8.053219e-5 |
GO:0032793 | positive regulation of CREB transcription factor activity | 8.142137e-5 |
GO:0046474 | glycerophospholipid biosynthetic process | 8.232427e-5 |
GO:0015684 | ferrous iron transport | 8.667661e-5 |
GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure | 8.861599e-5 |
GO:0006096 | glycolysis | 8.931102e-5 |
GO:0048790 | maintenance of presynaptic active zone structure | 9.222312e-5 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 9.222312e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 9.236996e-5 |
GO:0050819 | negative regulation of coagulation | 9.449375e-5 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 9.767032e-5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.015401e-4 |
GO:0042730 | fibrinolysis | 1.034737e-4 |
GO:0060713 | labyrinthine layer morphogenesis | 1.048656e-4 |
GO:0006458 | 'de novo' protein folding | 1.053558e-4 |
GO:0009416 | response to light stimulus | 1.057217e-4 |
GO:0016525 | negative regulation of angiogenesis | 1.066964e-4 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.075836e-4 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1.078690e-4 |
GO:0051917 | regulation of fibrinolysis | 1.080131e-4 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.109508e-4 |
GO:0070988 | demethylation | 1.152686e-4 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.261141e-4 |
GO:0003105 | negative regulation of glomerular filtration | 1.319636e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 1.320010e-4 |
GO:0060668 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling | 1.335864e-4 |
GO:0042886 | amide transport | 1.382746e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.382746e-4 |
GO:0006766 | vitamin metabolic process | 1.393923e-4 |
GO:0048873 | homeostasis of number of cells within a tissue | 1.400141e-4 |
GO:0009260 | ribonucleotide biosynthetic process | 1.401845e-4 |
GO:0001300 | chronological cell aging | 1.406764e-4 |
GO:0016311 | dephosphorylation | 1.457853e-4 |
GO:0002922 | positive regulation of humoral immune response | 1.536347e-4 |
GO:0006749 | glutathione metabolic process | 1.540519e-4 |
GO:0051918 | negative regulation of fibrinolysis | 1.570297e-4 |
GO:0044106 | cellular amine metabolic process | 1.597321e-4 |
GO:0045017 | glycerolipid biosynthetic process | 1.625550e-4 |
GO:0006241 | CTP biosynthetic process | 1.678454e-4 |
GO:0030421 | defecation | 1.681429e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 1.683839e-4 |
GO:0001893 | maternal placenta development | 1.695328e-4 |
GO:0050779 | RNA destabilization | 1.697222e-4 |
GO:0031400 | negative regulation of protein modification process | 1.799519e-4 |
GO:0006598 | polyamine catabolic process | 1.836298e-4 |
GO:0032754 | positive regulation of interleukin-5 production | 1.881547e-4 |
GO:0006590 | thyroid hormone generation | 1.901801e-4 |
GO:0061037 | negative regulation of cartilage development | 1.903939e-4 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 1.930004e-4 |
GO:0035510 | DNA dealkylation | 1.962552e-4 |
GO:0022009 | central nervous system vasculogenesis | 1.999876e-4 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 1.999876e-4 |
GO:0006897 | endocytosis | 2.006811e-4 |
GO:0007283 | spermatogenesis | 2.024344e-4 |
GO:0042558 | pteridine-containing compound metabolic process | 2.053336e-4 |
GO:0070498 | interleukin-1-mediated signaling pathway | 2.076217e-4 |
GO:0010529 | negative regulation of transposition | 2.116321e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.135833e-4 |
GO:0031338 | regulation of vesicle fusion | 2.214794e-4 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.215620e-4 |
GO:0009070 | serine family amino acid biosynthetic process | 2.219625e-4 |
GO:0048016 | inositol phosphate-mediated signaling | 2.243620e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 2.251573e-4 |
GO:0044027 | hypermethylation of CpG island | 2.278000e-4 |
GO:0032703 | negative regulation of interleukin-2 production | 2.287892e-4 |
GO:0015840 | urea transport | 2.315836e-4 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 2.317079e-4 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 2.338913e-4 |
GO:0043462 | regulation of ATPase activity | 2.380737e-4 |
GO:0006090 | pyruvate metabolic process | 2.386166e-4 |
GO:0048545 | response to steroid hormone stimulus | 2.488544e-4 |
GO:0015884 | folic acid transport | 2.564794e-4 |
GO:0045777 | positive regulation of blood pressure | 2.623915e-4 |
GO:0010669 | epithelial structure maintenance | 2.633612e-4 |
GO:0006937 | regulation of muscle contraction | 2.636066e-4 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 2.791588e-4 |
GO:0070633 | transepithelial transport | 2.794964e-4 |
GO:0006417 | regulation of translation | 2.870251e-4 |
GO:0034329 | cell junction assembly | 2.919359e-4 |
GO:0090257 | regulation of muscle system process | 2.927567e-4 |
GO:0006470 | protein dephosphorylation | 2.954613e-4 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 2.980977e-4 |
GO:0035039 | male pronucleus assembly | 3.062523e-4 |
GO:0048469 | cell maturation | 3.082647e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 3.083002e-4 |
GO:0001894 | tissue homeostasis | 3.103981e-4 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 3.310246e-4 |
GO:0007274 | neuromuscular synaptic transmission | 3.354699e-4 |
GO:0010887 | negative regulation of cholesterol storage | 3.385055e-4 |
GO:0060591 | chondroblast differentiation | 3.387811e-4 |
GO:0009812 | flavonoid metabolic process | 3.397549e-4 |
GO:0071529 | cementum mineralization | 3.429571e-4 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 3.429571e-4 |
GO:0033189 | response to vitamin A | 3.468925e-4 |
GO:0060876 | semicircular canal formation | 3.519288e-4 |
GO:0014041 | regulation of neuron maturation | 3.532939e-4 |
GO:0060306 | regulation of membrane repolarization | 3.563216e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.591333e-4 |
GO:0007296 | vitellogenesis | 3.617912e-4 |
GO:0006457 | protein folding | 3.655832e-4 |
GO:0072334 | UDP-galactose transmembrane transport | 3.681503e-4 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 3.749731e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 3.759447e-4 |
GO:0050710 | negative regulation of cytokine secretion | 3.764398e-4 |
GO:0035269 | protein O-linked mannosylation | 3.765722e-4 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.901778e-4 |
GO:0034505 | tooth mineralization | 3.980304e-4 |
GO:0009152 | purine ribonucleotide biosynthetic process | 4.067183e-4 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 4.172312e-4 |
GO:0045109 | intermediate filament organization | 4.206022e-4 |
GO:0032411 | positive regulation of transporter activity | 4.215831e-4 |
GO:0090343 | positive regulation of cell aging | 4.264928e-4 |
GO:0070170 | regulation of tooth mineralization | 4.376610e-4 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 4.406416e-4 |
GO:0010871 | negative regulation of receptor biosynthetic process | 4.437995e-4 |
GO:0072109 | glomerular mesangium development | 4.442515e-4 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 4.489757e-4 |
GO:0022417 | protein maturation by protein folding | 4.538955e-4 |
GO:0055067 | monovalent inorganic cation homeostasis | 4.568693e-4 |
GO:0008652 | cellular amino acid biosynthetic process | 4.616782e-4 |
GO:0015949 | nucleobase-containing small molecule interconversion | 4.699986e-4 |
GO:0070172 | positive regulation of tooth mineralization | 4.754585e-4 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 4.836231e-4 |
GO:0043046 | DNA methylation involved in gamete generation | 4.891015e-4 |
GO:0042711 | maternal behavior | 4.908372e-4 |
GO:0043163 | cell envelope organization | 4.931865e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 4.983481e-4 |
GO:0090398 | cellular senescence | 5.140900e-4 |
GO:0046618 | drug export | 5.175894e-4 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 5.175894e-4 |
GO:0014895 | smooth muscle hypertrophy | 5.175894e-4 |
GO:0050709 | negative regulation of protein secretion | 5.243666e-4 |
GO:0032606 | type I interferon production | 5.300401e-4 |
GO:0002682 | regulation of immune system process | 5.370441e-4 |
GO:0045006 | DNA deamination | 5.495522e-4 |
GO:0002376 | immune system process | 5.549137e-4 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 5.577087e-4 |
GO:0001937 | negative regulation of endothelial cell proliferation | 5.593408e-4 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 5.607330e-4 |
GO:0002086 | diaphragm contraction | 5.629396e-4 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 5.797397e-4 |
GO:0006228 | UTP biosynthetic process | 5.881840e-4 |
GO:0006165 | nucleoside diphosphate phosphorylation | 5.881840e-4 |
GO:0006183 | GTP biosynthetic process | 5.881840e-4 |
GO:0046007 | negative regulation of activated T cell proliferation | 5.989107e-4 |
GO:0006306 | DNA methylation | 6.136483e-4 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 6.215665e-4 |
GO:0031118 | rRNA pseudouridine synthesis | 6.215665e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 6.215665e-4 |
GO:0023035 | CD40 signaling pathway | 6.215665e-4 |
GO:0045905 | positive regulation of translational termination | 6.246152e-4 |
GO:0006452 | translational frameshifting | 6.246152e-4 |
GO:0045901 | positive regulation of translational elongation | 6.246152e-4 |
GO:0090130 | tissue migration | 6.297954e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 6.338802e-4 |
GO:0009164 | nucleoside catabolic process | 6.483328e-4 |
GO:0006085 | acetyl-CoA biosynthetic process | 6.641005e-4 |
GO:0046697 | decidualization | 6.723365e-4 |
GO:0006007 | glucose catabolic process | 6.795537e-4 |
GO:0060084 | synaptic transmission involved in micturition | 6.912986e-4 |
GO:0061180 | mammary gland epithelium development | 6.982176e-4 |
GO:0043086 | negative regulation of catalytic activity | 6.992383e-4 |
GO:0045835 | negative regulation of meiosis | 7.037468e-4 |
GO:0030046 | parallel actin filament bundle assembly | 7.176191e-4 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 7.188198e-4 |
GO:0015904 | tetracycline transport | 7.257477e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 7.257477e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 7.257477e-4 |
GO:0070489 | T cell aggregation | 7.424736e-4 |
GO:0006767 | water-soluble vitamin metabolic process | 7.465425e-4 |
GO:0090083 | regulation of inclusion body assembly | 7.573602e-4 |
GO:0046164 | alcohol catabolic process | 7.582524e-4 |
GO:0060406 | positive regulation of penile erection | 7.816136e-4 |
GO:0006402 | mRNA catabolic process | 7.850348e-4 |
GO:0009895 | negative regulation of catabolic process | 7.874635e-4 |
GO:0030035 | microspike assembly | 7.908043e-4 |
GO:0009259 | ribonucleotide metabolic process | 7.977267e-4 |
GO:0009972 | cytidine deamination | 7.980999e-4 |
GO:0071803 | positive regulation of podosome assembly | 7.993605e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 8.006105e-4 |
GO:0071506 | cellular response to mycophenolic acid | 8.006105e-4 |
GO:0072676 | lymphocyte migration | 8.012309e-4 |
GO:0050957 | equilibrioception | 8.060864e-4 |
GO:0048872 | homeostasis of number of cells | 8.130886e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 8.174406e-4 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 8.213966e-4 |
GO:0007265 | Ras protein signal transduction | 8.326870e-4 |
GO:0033687 | osteoblast proliferation | 8.565368e-4 |
GO:0007042 | lysosomal lumen acidification | 8.565368e-4 |
GO:0033233 | regulation of protein sumoylation | 8.579009e-4 |
GO:0043241 | protein complex disassembly | 8.621772e-4 |
GO:0006000 | fructose metabolic process | 8.633511e-4 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 8.749406e-4 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 8.789306e-4 |
GO:0009987 | cellular process | 8.792337e-4 |
GO:0014043 | negative regulation of neuron maturation | 8.928892e-4 |
GO:0046483 | heterocycle metabolic process | 9.096666e-4 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 9.479885e-4 |
GO:0045351 | type I interferon biosynthetic process | 9.482791e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 9.622665e-4 |
GO:0060435 | bronchiole development | 1.002873e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 1.016814e-3 |
GO:0032984 | macromolecular complex disassembly | 1.023048e-3 |
GO:0080111 | DNA demethylation | 1.036534e-3 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 1.043359e-3 |
GO:0001782 | B cell homeostasis | 1.043849e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.054965e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 1.054965e-3 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.071690e-3 |
GO:0019344 | cysteine biosynthetic process | 1.074999e-3 |
GO:0003093 | regulation of glomerular filtration | 1.087850e-3 |
GO:0048871 | multicellular organismal homeostasis | 1.088044e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 1.093977e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.100875e-3 |
GO:0045936 | negative regulation of phosphate metabolic process | 1.138333e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 1.153482e-3 |
GO:0051180 | vitamin transport | 1.195183e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 1.198598e-3 |
GO:0046292 | formaldehyde metabolic process | 1.219616e-3 |
GO:0030573 | bile acid catabolic process | 1.219616e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.238699e-3 |
GO:0032782 | bile acid secretion | 1.238699e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 1.255417e-3 |
GO:0031641 | regulation of myelination | 1.256269e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 1.283237e-3 |
GO:0002432 | granuloma formation | 1.288696e-3 |
GO:0008360 | regulation of cell shape | 1.291113e-3 |
GO:0060319 | primitive erythrocyte differentiation | 1.314902e-3 |
GO:0002575 | basophil chemotaxis | 1.314902e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.338750e-3 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 1.352408e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.352408e-3 |
GO:0060249 | anatomical structure homeostasis | 1.353443e-3 |
GO:0070383 | DNA cytosine deamination | 1.372408e-3 |
GO:0060457 | negative regulation of digestive system process | 1.372408e-3 |
GO:0070664 | negative regulation of leukocyte proliferation | 1.379807e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.384141e-3 |
GO:0012501 | programmed cell death | 1.385474e-3 |
GO:0014829 | vascular smooth muscle contraction | 1.406422e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1.407431e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.407431e-3 |
GO:0032753 | positive regulation of interleukin-4 production | 1.414405e-3 |
GO:0009226 | nucleotide-sugar biosynthetic process | 1.471629e-3 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 1.472473e-3 |
GO:0019402 | galactitol metabolic process | 1.472473e-3 |
GO:0015728 | mevalonate transport | 1.472473e-3 |
GO:0008217 | regulation of blood pressure | 1.478981e-3 |
GO:0071281 | cellular response to iron ion | 1.485251e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.493138e-3 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.493138e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.493138e-3 |
GO:0034219 | carbohydrate transmembrane transport | 1.494333e-3 |
GO:0007271 | synaptic transmission, cholinergic | 1.496381e-3 |
GO:0000212 | meiotic spindle organization | 1.518199e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 1.535806e-3 |
GO:0051972 | regulation of telomerase activity | 1.554559e-3 |
GO:0031347 | regulation of defense response | 1.578511e-3 |
GO:0006835 | dicarboxylic acid transport | 1.592916e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.603707e-3 |
GO:0010869 | regulation of receptor biosynthetic process | 1.620054e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 1.622101e-3 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 1.623956e-3 |
GO:0000185 | activation of MAPKKK activity | 1.650946e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 1.686725e-3 |
GO:0046034 | ATP metabolic process | 1.700398e-3 |
GO:0030502 | negative regulation of bone mineralization | 1.712504e-3 |
GO:0044092 | negative regulation of molecular function | 1.725903e-3 |
GO:0051186 | cofactor metabolic process | 1.775409e-3 |
GO:0046680 | response to DDT | 1.784736e-3 |
GO:0060623 | regulation of chromosome condensation | 1.784736e-3 |
GO:0071283 | cellular response to iron(III) ion | 1.784736e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 1.784736e-3 |
GO:0015761 | mannose transport | 1.784736e-3 |
GO:0019413 | acetate biosynthetic process | 1.784736e-3 |
GO:0019542 | propionate biosynthetic process | 1.784736e-3 |
GO:0019752 | carboxylic acid metabolic process | 1.798474e-3 |
GO:0071299 | cellular response to vitamin A | 1.818053e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 1.851448e-3 |
GO:0002316 | follicular B cell differentiation | 1.856066e-3 |
GO:0033033 | negative regulation of myeloid cell apoptosis | 1.862899e-3 |
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 1.862899e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.891425e-3 |
GO:0048708 | astrocyte differentiation | 1.905828e-3 |
GO:0061024 | membrane organization | 1.924323e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.928096e-3 |
GO:0071217 | cellular response to external biotic stimulus | 1.958593e-3 |
GO:0016142 | O-glycoside catabolic process | 1.958593e-3 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 1.958593e-3 |
GO:2000774 | positive regulation of cellular senescence | 2.011402e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 2.011402e-3 |
GO:0016044 | cellular membrane organization | 2.018505e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 2.028721e-3 |
GO:0001890 | placenta development | 2.030271e-3 |
GO:0046847 | filopodium assembly | 2.039642e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.043561e-3 |
GO:0043534 | blood vessel endothelial cell migration | 2.052074e-3 |
GO:0071316 | cellular response to nicotine | 2.064116e-3 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 2.070532e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 2.080943e-3 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 2.084306e-3 |
GO:0006082 | organic acid metabolic process | 2.113239e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 2.117369e-3 |
GO:0006700 | C21-steroid hormone biosynthetic process | 2.136604e-3 |
GO:0001933 | negative regulation of protein phosphorylation | 2.182438e-3 |
GO:0060080 | regulation of inhibitory postsynaptic membrane potential | 2.230897e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 2.253603e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 2.264623e-3 |
GO:0031077 | post-embryonic camera-type eye development | 2.272765e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 2.295916e-3 |
GO:0050901 | leukocyte tethering or rolling | 2.295969e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 2.300320e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 2.304158e-3 |
GO:0031365 | N-terminal protein amino acid modification | 2.340898e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.357393e-3 |
GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 2.357491e-3 |
GO:0046185 | aldehyde catabolic process | 2.357866e-3 |
GO:0007202 | activation of phospholipase C activity | 2.360305e-3 |
GO:0050856 | regulation of T cell receptor signaling pathway | 2.389958e-3 |
GO:0006942 | regulation of striated muscle contraction | 2.398125e-3 |
GO:0006505 | GPI anchor metabolic process | 2.405941e-3 |
GO:0042180 | cellular ketone metabolic process | 2.407147e-3 |
GO:0009408 | response to heat | 2.441853e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0035094 | response to nicotine | 5.162701e-12 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 6.456554e-11 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.611057e-10 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 8.584097e-10 |
GO:0002636 | positive regulation of germinal center formation | 1.758536e-9 |
GO:0006631 | fatty acid metabolic process | 2.194482e-9 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 2.802214e-9 |
GO:2000107 | negative regulation of leukocyte apoptosis | 3.615392e-9 |
GO:0090083 | regulation of inclusion body assembly | 4.645765e-9 |
GO:0002906 | negative regulation of mature B cell apoptosis | 9.482727e-9 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 1.089274e-8 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1.159861e-8 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.254965e-8 |
GO:0002385 | mucosal immune response | 1.325824e-8 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.618503e-8 |
GO:0019724 | B cell mediated immunity | 2.066811e-8 |
GO:0006206 | pyrimidine base metabolic process | 2.494748e-8 |
GO:0016064 | immunoglobulin mediated immune response | 2.677653e-8 |
GO:0002251 | organ or tissue specific immune response | 3.351730e-8 |
GO:0010898 | positive regulation of triglyceride catabolic process | 3.581972e-8 |
GO:0034442 | regulation of lipoprotein oxidation | 4.294882e-8 |
GO:0044255 | cellular lipid metabolic process | 5.527224e-8 |
GO:0060193 | positive regulation of lipase activity | 6.020695e-8 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 6.434704e-8 |
GO:0002830 | positive regulation of type 2 immune response | 7.587367e-8 |
GO:0042180 | cellular ketone metabolic process | 9.012294e-8 |
GO:0006082 | organic acid metabolic process | 1.009537e-7 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.520028e-7 |
GO:0006952 | defense response | 1.626452e-7 |
GO:0090084 | negative regulation of inclusion body assembly | 1.750380e-7 |
GO:0007586 | digestion | 1.816381e-7 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 2.318265e-7 |
GO:0019752 | carboxylic acid metabolic process | 2.343868e-7 |
GO:0006629 | lipid metabolic process | 2.420127e-7 |
GO:0006982 | response to lipid hydroperoxide | 2.425350e-7 |
GO:0002903 | negative regulation of B cell apoptosis | 2.587477e-7 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.106184e-7 |
GO:0050746 | regulation of lipoprotein metabolic process | 7.271057e-7 |
GO:0002443 | leukocyte mediated immunity | 7.956467e-7 |
GO:0032700 | negative regulation of interleukin-17 production | 8.548444e-7 |
GO:0021564 | vagus nerve development | 8.935345e-7 |
GO:0001516 | prostaglandin biosynthetic process | 9.244984e-7 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.017072e-6 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 1.040733e-6 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.062136e-6 |
GO:0051135 | positive regulation of NK T cell activation | 1.120209e-6 |
GO:0045940 | positive regulation of steroid metabolic process | 1.375322e-6 |
GO:0006693 | prostaglandin metabolic process | 1.675481e-6 |
GO:0010896 | regulation of triglyceride catabolic process | 1.745486e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.895533e-6 |
GO:2001020 | regulation of response to DNA damage stimulus | 1.913727e-6 |
GO:0055114 | oxidation-reduction process | 1.919094e-6 |
GO:0044281 | small molecule metabolic process | 2.029727e-6 |
GO:0072529 | pyrimidine-containing compound catabolic process | 2.039649e-6 |
GO:0002227 | innate immune response in mucosa | 2.102707e-6 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.839428e-6 |
GO:0035082 | axoneme assembly | 2.988974e-6 |
GO:0030300 | regulation of intestinal cholesterol absorption | 3.087093e-6 |
GO:0002449 | lymphocyte mediated immunity | 3.227429e-6 |
GO:0072376 | protein activation cascade | 3.270998e-6 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 3.374257e-6 |
GO:0006956 | complement activation | 3.468378e-6 |
GO:0045834 | positive regulation of lipid metabolic process | 3.545714e-6 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.735329e-6 |
GO:0032787 | monocarboxylic acid metabolic process | 3.782239e-6 |
GO:0046456 | icosanoid biosynthetic process | 3.881989e-6 |
GO:0032846 | positive regulation of homeostatic process | 4.148324e-6 |
GO:0006707 | cholesterol catabolic process | 4.865246e-6 |
GO:0021563 | glossopharyngeal nerve development | 5.293193e-6 |
GO:0061077 | chaperone-mediated protein folding | 5.790894e-6 |
GO:0006360 | transcription from RNA polymerase I promoter | 5.878231e-6 |
GO:0015914 | phospholipid transport | 6.554124e-6 |
GO:0046394 | carboxylic acid biosynthetic process | 6.804506e-6 |
GO:0002579 | positive regulation of antigen processing and presentation | 6.912489e-6 |
GO:0019229 | regulation of vasoconstriction | 8.414748e-6 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 9.278867e-6 |
GO:0070228 | regulation of lymphocyte apoptosis | 1.064389e-5 |
GO:0006208 | pyrimidine base catabolic process | 1.106589e-5 |
GO:0009719 | response to endogenous stimulus | 1.250532e-5 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.288452e-5 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1.506100e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 1.509301e-5 |
GO:0001562 | response to protozoan | 1.597030e-5 |
GO:0043279 | response to alkaloid | 1.612045e-5 |
GO:0006633 | fatty acid biosynthetic process | 1.690882e-5 |
GO:0009725 | response to hormone stimulus | 1.810060e-5 |
GO:0008203 | cholesterol metabolic process | 2.190411e-5 |
GO:0090208 | positive regulation of triglyceride metabolic process | 2.367042e-5 |
GO:0072329 | monocarboxylic acid catabolic process | 2.388613e-5 |
GO:0046037 | GMP metabolic process | 2.502270e-5 |
GO:0045087 | innate immune response | 2.507340e-5 |
GO:0006690 | icosanoid metabolic process | 2.657760e-5 |
GO:0048486 | parasympathetic nervous system development | 2.758894e-5 |
GO:0006991 | response to sterol depletion | 2.878621e-5 |
GO:0071316 | cellular response to nicotine | 2.900911e-5 |
GO:0019218 | regulation of steroid metabolic process | 3.029004e-5 |
GO:0044243 | multicellular organismal catabolic process | 3.190560e-5 |
GO:0051588 | regulation of neurotransmitter transport | 3.243968e-5 |
GO:0010661 | positive regulation of muscle cell apoptosis | 3.263171e-5 |
GO:0030574 | collagen catabolic process | 3.287569e-5 |
GO:0046395 | carboxylic acid catabolic process | 3.336713e-5 |
GO:0032729 | positive regulation of interferon-gamma production | 3.402662e-5 |
GO:0030157 | pancreatic juice secretion | 3.853519e-5 |
GO:0015816 | glycine transport | 3.853519e-5 |
GO:0016074 | snoRNA metabolic process | 3.874173e-5 |
GO:0009112 | nucleobase metabolic process | 3.877831e-5 |
GO:0060760 | positive regulation of response to cytokine stimulus | 4.046781e-5 |
GO:0035986 | senescence-associated heterochromatin focus formation | 4.302576e-5 |
GO:0090402 | oncogene-induced senescence | 4.302576e-5 |
GO:2000774 | positive regulation of cellular senescence | 4.302576e-5 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 4.302576e-5 |
GO:0008610 | lipid biosynthetic process | 4.419178e-5 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 4.870897e-5 |
GO:0007288 | sperm axoneme assembly | 4.941412e-5 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 4.984466e-5 |
GO:0035036 | sperm-egg recognition | 5.342367e-5 |
GO:0009062 | fatty acid catabolic process | 5.373366e-5 |
GO:0021783 | preganglionic parasympathetic nervous system development | 5.541558e-5 |
GO:0032642 | regulation of chemokine production | 5.571265e-5 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 6.320929e-5 |
GO:0044058 | regulation of digestive system process | 6.325605e-5 |
GO:0006953 | acute-phase response | 6.519271e-5 |
GO:0045980 | negative regulation of nucleotide metabolic process | 7.009864e-5 |
GO:0016125 | sterol metabolic process | 7.150018e-5 |
GO:0033344 | cholesterol efflux | 7.314602e-5 |
GO:0002833 | positive regulation of response to biotic stimulus | 7.500201e-5 |
GO:0009071 | serine family amino acid catabolic process | 7.533356e-5 |
GO:0015790 | UDP-xylose transport | 7.874582e-5 |
GO:0015788 | UDP-N-acetylglucosamine transport | 7.874582e-5 |
GO:0071874 | cellular response to norepinephrine stimulus | 8.095649e-5 |
GO:0048016 | inositol phosphate-mediated signaling | 8.494418e-5 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 8.741211e-5 |
GO:0006378 | mRNA polyadenylation | 9.133450e-5 |
GO:0018342 | protein prenylation | 1.042257e-4 |
GO:0002821 | positive regulation of adaptive immune response | 1.091800e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 1.149052e-4 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 1.159164e-4 |
GO:0019430 | removal of superoxide radicals | 1.219436e-4 |
GO:0006066 | alcohol metabolic process | 1.242211e-4 |
GO:0045907 | positive regulation of vasoconstriction | 1.286445e-4 |
GO:0006954 | inflammatory response | 1.305910e-4 |
GO:0002699 | positive regulation of immune effector process | 1.310905e-4 |
GO:0046113 | nucleobase catabolic process | 1.479980e-4 |
GO:0002577 | regulation of antigen processing and presentation | 1.664261e-4 |
GO:0001578 | microtubule bundle formation | 1.848569e-4 |
GO:0048630 | skeletal muscle tissue growth | 1.909918e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1.920397e-4 |
GO:0097035 | regulation of membrane lipid distribution | 2.022947e-4 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.022947e-4 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 2.130776e-4 |
GO:0015761 | mannose transport | 2.250246e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 2.276377e-4 |
GO:0042832 | defense response to protozoan | 2.291035e-4 |
GO:0070244 | negative regulation of thymocyte apoptosis | 2.340901e-4 |
GO:0042663 | regulation of endodermal cell fate specification | 2.340901e-4 |
GO:0051702 | interaction with symbiont | 2.388841e-4 |
GO:2000106 | regulation of leukocyte apoptosis | 2.395074e-4 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.460404e-4 |
GO:0043627 | response to estrogen stimulus | 2.490772e-4 |
GO:0071242 | cellular response to ammonium ion | 2.616899e-4 |
GO:0006578 | betaine biosynthetic process | 2.684645e-4 |
GO:0048242 | epinephrine secretion | 2.863242e-4 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 2.863317e-4 |
GO:0010193 | response to ozone | 3.043868e-4 |
GO:0045780 | positive regulation of bone resorption | 3.085129e-4 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.104419e-4 |
GO:0065005 | protein-lipid complex assembly | 3.145886e-4 |
GO:0010466 | negative regulation of peptidase activity | 3.162225e-4 |
GO:0030817 | regulation of cAMP biosynthetic process | 3.179440e-4 |
GO:0001706 | endoderm formation | 3.299977e-4 |
GO:0090238 | positive regulation of arachidonic acid secretion | 3.475446e-4 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 3.481058e-4 |
GO:0032722 | positive regulation of chemokine production | 3.575292e-4 |
GO:0010224 | response to UV-B | 3.730506e-4 |
GO:0008535 | respiratory chain complex IV assembly | 3.739339e-4 |
GO:0046475 | glycerophospholipid catabolic process | 3.859971e-4 |
GO:0002837 | regulation of immune response to tumor cell | 3.952537e-4 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 3.975928e-4 |
GO:0006663 | platelet activating factor biosynthetic process | 4.040901e-4 |
GO:0042396 | phosphagen biosynthetic process | 4.042913e-4 |
GO:0070243 | regulation of thymocyte apoptosis | 4.086021e-4 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 4.275169e-4 |
GO:0007339 | binding of sperm to zona pellucida | 4.325492e-4 |
GO:0002839 | positive regulation of immune response to tumor cell | 4.359906e-4 |
GO:0001867 | complement activation, lectin pathway | 4.517416e-4 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 4.770874e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 4.783432e-4 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 4.783432e-4 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 4.783432e-4 |
GO:0010518 | positive regulation of phospholipase activity | 4.982554e-4 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 5.009638e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 5.234489e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 5.331406e-4 |
GO:0048148 | behavioral response to cocaine | 5.380355e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 5.577582e-4 |
GO:0043085 | positive regulation of catalytic activity | 5.848602e-4 |
GO:0071422 | succinate transmembrane transport | 5.879433e-4 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 5.879433e-4 |
GO:0015889 | cobalamin transport | 5.879433e-4 |
GO:0045908 | negative regulation of vasodilation | 6.112841e-4 |
GO:0050810 | regulation of steroid biosynthetic process | 6.242167e-4 |
GO:0070232 | regulation of T cell apoptosis | 6.381309e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 6.430216e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 6.430216e-4 |
GO:0018344 | protein geranylgeranylation | 6.430216e-4 |
GO:0016140 | O-glycoside metabolic process | 6.430216e-4 |
GO:0030967 | ER-nuclear sterol response pathway | 6.477122e-4 |
GO:0006958 | complement activation, classical pathway | 6.497147e-4 |
GO:0034105 | positive regulation of tissue remodeling | 6.500310e-4 |
GO:0006108 | malate metabolic process | 6.669267e-4 |
GO:0046060 | dATP metabolic process | 6.829884e-4 |
GO:0046548 | retinal rod cell development | 6.845807e-4 |
GO:0000305 | response to oxygen radical | 7.072672e-4 |
GO:0030814 | regulation of cAMP metabolic process | 7.210434e-4 |
GO:0031649 | heat generation | 7.456666e-4 |
GO:0019932 | second-messenger-mediated signaling | 7.486610e-4 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 7.686131e-4 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 7.714351e-4 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 7.714351e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 7.753088e-4 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 7.875246e-4 |
GO:0033700 | phospholipid efflux | 7.891043e-4 |
GO:0090022 | regulation of neutrophil chemotaxis | 8.012837e-4 |
GO:0035987 | endodermal cell differentiation | 8.012837e-4 |
GO:0050778 | positive regulation of immune response | 8.017181e-4 |
GO:0001659 | temperature homeostasis | 8.029095e-4 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 8.264662e-4 |
GO:0032649 | regulation of interferon-gamma production | 8.450614e-4 |
GO:0002071 | glandular epithelial cell maturation | 8.471560e-4 |
GO:0008594 | photoreceptor cell morphogenesis | 8.471560e-4 |
GO:0006635 | fatty acid beta-oxidation | 8.525988e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 8.700626e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 8.700626e-4 |
GO:0006546 | glycine catabolic process | 8.700626e-4 |
GO:0048240 | sperm capacitation | 8.871780e-4 |
GO:0008645 | hexose transport | 9.035732e-4 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 9.169618e-4 |
GO:0071702 | organic substance transport | 9.291681e-4 |
GO:0046928 | regulation of neurotransmitter secretion | 9.294826e-4 |
GO:0044236 | multicellular organismal metabolic process | 9.311265e-4 |
GO:0019216 | regulation of lipid metabolic process | 9.507762e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 9.624078e-4 |
GO:0032868 | response to insulin stimulus | 1.036591e-3 |
GO:0052547 | regulation of peptidase activity | 1.036824e-3 |
GO:0042129 | regulation of T cell proliferation | 1.040964e-3 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 1.080549e-3 |
GO:0002077 | acrosome matrix dispersal | 1.105161e-3 |
GO:0051186 | cofactor metabolic process | 1.108646e-3 |
GO:0072593 | reactive oxygen species metabolic process | 1.109303e-3 |
GO:0009988 | cell-cell recognition | 1.142752e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 1.159237e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.163688e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 1.173793e-3 |
GO:0050790 | regulation of catalytic activity | 1.179668e-3 |
GO:0010976 | positive regulation of neuron projection development | 1.193198e-3 |
GO:0043094 | cellular metabolic compound salvage | 1.208581e-3 |
GO:0050766 | positive regulation of phagocytosis | 1.272027e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 1.283795e-3 |
GO:0019882 | antigen processing and presentation | 1.284749e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 1.354980e-3 |
GO:0043434 | response to peptide hormone stimulus | 1.376856e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.379894e-3 |
GO:0006734 | NADH metabolic process | 1.390113e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.395255e-3 |
GO:0018206 | peptidyl-methionine modification | 1.436202e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.436202e-3 |
GO:0007493 | endodermal cell fate determination | 1.437873e-3 |
GO:0002513 | tolerance induction to self antigen | 1.444681e-3 |
GO:0035023 | regulation of Rho protein signal transduction | 1.448807e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.499876e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 1.504386e-3 |
GO:0048241 | epinephrine transport | 1.508632e-3 |
GO:0060913 | cardiac cell fate determination | 1.541039e-3 |
GO:0032571 | response to vitamin K | 1.541039e-3 |
GO:0072181 | mesonephric duct formation | 1.557877e-3 |
GO:0002902 | regulation of B cell apoptosis | 1.565652e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.615306e-3 |
GO:0071705 | nitrogen compound transport | 1.627719e-3 |
GO:0010872 | regulation of cholesterol esterification | 1.634657e-3 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 1.660510e-3 |
GO:0050432 | catecholamine secretion | 1.672128e-3 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.712893e-3 |
GO:0050671 | positive regulation of lymphocyte proliferation | 1.714781e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 1.732494e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 1.733845e-3 |
GO:0002684 | positive regulation of immune system process | 1.750021e-3 |
GO:0032859 | activation of Ral GTPase activity | 1.751342e-3 |
GO:0042157 | lipoprotein metabolic process | 1.760670e-3 |
GO:0006641 | triglyceride metabolic process | 1.762464e-3 |
GO:0046503 | glycerolipid catabolic process | 1.806844e-3 |
GO:0051345 | positive regulation of hydrolase activity | 1.822092e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 1.837444e-3 |
GO:0006801 | superoxide metabolic process | 1.837609e-3 |
GO:0043922 | negative regulation by host of viral transcription | 1.853583e-3 |
GO:0006959 | humoral immune response | 1.876735e-3 |
GO:0007109 | cytokinesis, completion of separation | 1.894554e-3 |
GO:0055090 | acylglycerol homeostasis | 1.905977e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.929877e-3 |
GO:0043691 | reverse cholesterol transport | 1.944803e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 1.952727e-3 |
GO:0070233 | negative regulation of T cell apoptosis | 1.969448e-3 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.971314e-3 |
GO:0010033 | response to organic substance | 1.984817e-3 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 1.994814e-3 |
GO:0008202 | steroid metabolic process | 1.995054e-3 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 2.021025e-3 |
GO:0032218 | riboflavin transport | 2.036889e-3 |
GO:0033566 | gamma-tubulin complex localization | 2.036889e-3 |
GO:0016068 | type I hypersensitivity | 2.036889e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.036889e-3 |
GO:0000053 | argininosuccinate metabolic process | 2.036889e-3 |
GO:0000303 | response to superoxide | 2.040369e-3 |
GO:0045332 | phospholipid translocation | 2.044049e-3 |
GO:0016042 | lipid catabolic process | 2.088597e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 2.106235e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2.151685e-3 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 2.162166e-3 |
GO:0050999 | regulation of nitric-oxide synthase activity | 2.193912e-3 |
GO:0010522 | regulation of calcium ion transport into cytosol | 2.249080e-3 |
GO:0002526 | acute inflammatory response | 2.263373e-3 |
GO:0032368 | regulation of lipid transport | 2.273174e-3 |
GO:0030321 | transepithelial chloride transport | 2.288919e-3 |
GO:0031638 | zymogen activation | 2.321288e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 2.328421e-3 |
GO:0017004 | cytochrome complex assembly | 2.355629e-3 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 2.355629e-3 |
GO:0032963 | collagen metabolic process | 2.368736e-3 |
GO:0070665 | positive regulation of leukocyte proliferation | 2.388471e-3 |
GO:0043631 | RNA polyadenylation | 2.406901e-3 |
GO:0032025 | response to cobalt ion | 2.461689e-3 |
GO:0045089 | positive regulation of innate immune response | 2.479711e-3 |
GO:0046185 | aldehyde catabolic process | 2.512528e-3 |
GO:0046333 | octopamine metabolic process | 2.512528e-3 |
GO:0035106 | operant conditioning | 2.512528e-3 |
GO:0042309 | homoiothermy | 2.512528e-3 |
GO:0030573 | bile acid catabolic process | 2.512528e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 2.512701e-3 |
GO:0042107 | cytokine metabolic process | 2.515505e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.515505e-3 |
GO:0032897 | negative regulation of viral transcription | 2.533450e-3 |
GO:0032276 | regulation of gonadotropin secretion | 2.533450e-3 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 2.542552e-3 |
GO:0009611 | response to wounding | 2.565038e-3 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 2.571150e-3 |
GO:0032768 | regulation of monooxygenase activity | 2.636134e-3 |
GO:0002703 | regulation of leukocyte mediated immunity | 2.646535e-3 |
GO:0009190 | cyclic nucleotide biosynthetic process | 2.655734e-3 |
GO:0006177 | GMP biosynthetic process | 2.665542e-3 |
GO:0015844 | monoamine transport | 2.681866e-3 |
GO:0015749 | monosaccharide transport | 2.702536e-3 |
GO:0006544 | glycine metabolic process | 2.735624e-3 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 2.739537e-3 |
GO:0031124 | mRNA 3'-end processing | 2.766221e-3 |
GO:0044283 | small molecule biosynthetic process | 2.774237e-3 |
GO:0071375 | cellular response to peptide hormone stimulus | 2.785321e-3 |
GO:0010273 | detoxification of copper ion | 2.828909e-3 |
GO:0070328 | triglyceride homeostasis | 2.861328e-3 |
GO:0006706 | steroid catabolic process | 2.919332e-3 |
GO:0042742 | defense response to bacterium | 2.930034e-3 |
GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 2.934197e-3 |
GO:0070166 | enamel mineralization | 2.934197e-3 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.934197e-3 |
GO:0044093 | positive regulation of molecular function | 2.962842e-3 |
GO:0060051 | negative regulation of protein glycosylation | 3.032456e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 3.034821e-3 |
GO:2000297 | negative regulation of synapse maturation | 3.090198e-3 |
GO:0039020 | pronephric nephron tubule development | 3.090198e-3 |
GO:0035565 | regulation of pronephros size | 3.090198e-3 |
GO:0000038 | very long-chain fatty acid metabolic process | 3.135266e-3 |
GO:0010288 | response to lead ion | 3.171407e-3 |
GO:0051251 | positive regulation of lymphocyte activation | 3.273104e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 3.334044e-3 |
GO:0006006 | glucose metabolic process | 3.371370e-3 |
GO:0045807 | positive regulation of endocytosis | 3.457847e-3 |
GO:0010935 | regulation of macrophage cytokine production | 3.512711e-3 |
GO:0035634 | response to stilbenoid | 3.527387e-3 |
GO:0010517 | regulation of phospholipase activity | 3.559702e-3 |
GO:0042840 | D-glucuronate catabolic process | 3.569001e-3 |
GO:0045751 | negative regulation of Toll signaling pathway | 3.569001e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 3.569001e-3 |
GO:0060299 | negative regulation of sarcomere organization | 3.569001e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 3.569001e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 3.569001e-3 |
GO:0035582 | negative regulation of BMP signaling pathway by extracellular sequestering of BMP | 3.569001e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 3.569001e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 3.569001e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 3.569001e-3 |
GO:0035725 | sodium ion transmembrane transport | 3.603607e-3 |
GO:0042102 | positive regulation of T cell proliferation | 3.619060e-3 |
GO:0002697 | regulation of immune effector process | 3.628380e-3 |
GO:0031576 | G2/M transition checkpoint | 3.639715e-3 |
GO:0006821 | chloride transport | 3.691947e-3 |
GO:0008286 | insulin receptor signaling pathway | 3.787798e-3 |
GO:0051336 | regulation of hydrolase activity | 3.821106e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 3.823011e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 3.836608e-3 |
GO:0015937 | coenzyme A biosynthetic process | 3.851012e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 3.855532e-3 |
GO:0060674 | placenta blood vessel development | 3.872647e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 3.988362e-3 |
GO:0046847 | filopodium assembly | 4.020279e-3 |
GO:0018345 | protein palmitoylation | 4.066897e-3 |
GO:0006725 | cellular aromatic compound metabolic process | 4.151556e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 4.201080e-3 |
GO:0014070 | response to organic cyclic compound | 4.231228e-3 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 4.382140e-3 |
GO:0060191 | regulation of lipase activity | 4.490238e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 4.496834e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 4.496834e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 4.496834e-3 |
GO:0032869 | cellular response to insulin stimulus | 4.544167e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 4.552094e-3 |
GO:0046514 | ceramide catabolic process | 4.605051e-3 |
GO:0071731 | response to nitric oxide | 4.647272e-3 |
GO:0021554 | optic nerve development | 4.647272e-3 |
GO:0046880 | regulation of follicle-stimulating hormone secretion | 4.689603e-3 |
GO:0051856 | adhesion to symbiont | 4.754278e-3 |
GO:0051341 | regulation of oxidoreductase activity | 4.755639e-3 |
GO:0048545 | response to steroid hormone stimulus | 4.763832e-3 |
GO:0044282 | small molecule catabolic process | 4.772483e-3 |
GO:0007205 | activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 4.800754e-3 |
GO:0097152 | mesenchymal cell apoptosis | 4.818462e-3 |
GO:0003273 | cell migration involved in endocardial cushion formation | 4.818462e-3 |
GO:0015758 | glucose transport | 4.968027e-3 |
GO:0006030 | chitin metabolic process | 5.017002e-3 |
GO:0010876 | lipid localization | 5.021263e-3 |
GO:0010863 | positive regulation of phospholipase C activity | 5.024226e-3 |
GO:0042104 | positive regulation of activated T cell proliferation | 5.071282e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 5.163251e-3 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 5.163251e-3 |
GO:0071257 | cellular response to electrical stimulus | 5.214030e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.234443e-3 |
GO:0001895 | retina homeostasis | 5.234443e-3 |
GO:0061078 | positive regulation of prostaglandin secretion involved in immune response | 5.250442e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 5.250442e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.250442e-3 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 5.250442e-3 |
GO:0002365 | gamma-delta T cell lineage commitment | 5.250442e-3 |
GO:0016142 | O-glycoside catabolic process | 5.250442e-3 |
GO:0032620 | interleukin-17 production | 5.250442e-3 |
GO:0032707 | negative regulation of interleukin-23 production | 5.250442e-3 |
GO:0010951 | negative regulation of endopeptidase activity | 5.332064e-3 |
GO:0035025 | positive regulation of Rho protein signal transduction | 5.389509e-3 |
GO:0032863 | activation of Rac GTPase activity | 5.389509e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.389509e-3 |
GO:0009314 | response to radiation | 5.428400e-3 |
GO:0044242 | cellular lipid catabolic process | 5.430510e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 5.482167e-3 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 5.482167e-3 |
GO:0042089 | cytokine biosynthetic process | 5.489128e-3 |
GO:0006110 | regulation of glycolysis | 5.489270e-3 |
GO:0005996 | monosaccharide metabolic process | 5.491844e-3 |
GO:0070682 | proteasome regulatory particle assembly | 5.606087e-3 |
GO:0018158 | protein oxidation | 5.606087e-3 |
GO:0035129 | post-embryonic hindlimb morphogenesis | 5.606087e-3 |
GO:0006955 | immune response | 5.757267e-3 |
GO:0043248 | proteasome assembly | 5.875275e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.990519e-3 |
GO:0001660 | fever generation | 6.009410e-3 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 6.030945e-3 |
GO:0015732 | prostaglandin transport | 6.030945e-3 |
GO:0002706 | regulation of lymphocyte mediated immunity | 6.043150e-3 |
GO:0035066 | positive regulation of histone acetylation | 6.066982e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.139544e-3 |
GO:0048268 | clathrin coat assembly | 6.148217e-3 |
GO:0071495 | cellular response to endogenous stimulus | 6.151896e-3 |
GO:0045329 | carnitine biosynthetic process | 6.163549e-3 |
GO:0033278 | cell proliferation in midbrain | 6.163549e-3 |
GO:0019585 | glucuronate metabolic process | 6.190537e-3 |
GO:0050909 | sensory perception of taste | 6.211293e-3 |
GO:0060056 | mammary gland involution | 6.223158e-3 |
GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback | 6.227930e-3 |
GO:0001711 | endodermal cell fate commitment | 6.251839e-3 |
GO:0001736 | establishment of planar polarity | 6.251839e-3 |
GO:0022614 | membrane to membrane docking | 6.256999e-3 |
GO:0042035 | regulation of cytokine biosynthetic process | 6.319637e-3 |
GO:0050714 | positive regulation of protein secretion | 6.406511e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 6.444773e-3 |
GO:0035813 | regulation of renal sodium excretion | 6.483918e-3 |
GO:0006968 | cellular defense response | 6.499816e-3 |
GO:0006282 | regulation of DNA repair | 6.514379e-3 |
GO:0006555 | methionine metabolic process | 6.585091e-3 |
GO:0006869 | lipid transport | 6.618508e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 6.628448e-3 |
GO:0021853 | cerebral cortex GABAergic interneuron migration | 6.628448e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 6.660305e-3 |
GO:0007202 | activation of phospholipase C activity | 6.758829e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 6.779554e-3 |
GO:0007164 | establishment of tissue polarity | 6.838907e-3 |
GO:0050994 | regulation of lipid catabolic process | 6.852678e-3 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 6.866111e-3 |
GO:0060346 | bone trabecula formation | 6.885817e-3 |
GO:0002252 | immune effector process | 6.895114e-3 |
GO:0030168 | platelet activation | 7.036210e-3 |
GO:0009116 | nucleoside metabolic process | 7.066316e-3 |
GO:0043101 | purine-containing compound salvage | 7.168844e-3 |
GO:0019730 | antimicrobial humoral response | 7.168844e-3 |
GO:0015840 | urea transport | 7.168844e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 7.244096e-3 |
GO:0034505 | tooth mineralization | 7.260578e-3 |